Skip to main content

Advertisement

SpringerLink
Log in

The treatment of overactive bladder: A primary care provider’s perspective

  • Invited Commentary
  • Published:
Current Urology Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References and Recommended Reading

  1. Stewart WF, Van Rooyen JB, Cundiff GW, et al.: Prevalence and burden of overactive bladder in the United States. World J Urol 2003, 20:327–336.

    PubMed  CAS  Google Scholar 

  2. American Medical Association: Physician Characteristics and Distribution in the U.S., 2008. Chicago, IL: American Medical Association; 2008.

    Google Scholar 

  3. Rosenberg MT: Overactive bladder made ridiculously simple? Int J Clin Pract 2006, 60:631–633.

    Article  PubMed  CAS  Google Scholar 

  4. Rosenberg MT: The sad, misunderstood prostate: understanding perceptions and reality. Int J Clin Pract 2006, 60:1148–1149.

    Article  PubMed  CAS  Google Scholar 

  5. Rosenberg MT: Master of nothing but knower of all. Int J Clin Pract 2008, 62:668–669.

    Article  PubMed  CAS  Google Scholar 

  6. Rosenberg MT: Urologists: please teach us PCPs about zebras. Urology Times. September 1, 2007.

  7. American Council for Graduate Medicine Education: ACGME program requirements for graduate medical education in family practice. Section IV.A.b).(5).(d):26. Available at http://www.acgme.org/acWebsite/downloads/RRC_progReq/120pr07012007.pdf. Accessed June 19, 2008.

  8. Rosenberg MT, Newman DK, Tallman CT, Page SA: Overactive bladder: recognition requires vigilance for symptoms. Clev Clin J Med 2007, 74:S21–S29.

    Article  Google Scholar 

  9. Rosenberg MT, Staskin DR, Kaplan SR, et al.: A practical guide to the evaluation and treatment of male lower urinary tract symptoms in the primary care setting. Int J Clin Pract 2007, 61:1535–1546.

    Article  PubMed  CAS  Google Scholar 

  10. Abrams P, Cardozo L, Fall M, et al.: The standardization of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Am J Obstet Gynecol 2002, 187:116–126.

    Article  PubMed  Google Scholar 

  11. Wein AJ: Pathophysiology and categorization of voiding dysfunction. In Campbell’s Urology, edn 7. Edited by Walsh PC, Retik AB, Vaughan ED, et al. Philadelphia: WB Saunders; 1998:917–918.

    Google Scholar 

  12. Roberts R, Bavendam T, Glasser DB, et al.: Tolterodine extended release improves patient-reported outcomes in overactive bladder: results from the IMPACT trial. Int J Clin Pract 2006, 60:752–758.

    Article  PubMed  CAS  Google Scholar 

  13. Elinoff V, Bavendam T, Glaser D, et al.: Symptom-specific efficacy of tolterodine extended release in patients with overactive bladder: the IMPACT trial. Int J Clin Pract 2006, 60:745–751.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Mid Michigan Health Centers, 214 North West Ave, Jackson, MI, 49201, USA

    Matt T. Rosenberg

Authors
  1. Matt T. Rosenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Matt T. Rosenberg.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rosenberg, M.T. The treatment of overactive bladder: A primary care provider’s perspective. Curr Urol Rep 9, 428–432 (2008). https://doi.org/10.1007/s11934-008-0073-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11934-008-0073-5

Keywords

Search

Navigation